Literature DB >> 22856385

Susceptibility of mitochondrial electron-transport complexes to oxidative damage. Focus on cytochrome c oxidase.

Andrej Musatov1, Neal C Robinson.   

Abstract

Reactive oxygen species (ROS) are associated with a number of mitochondrial disorders. These include: ischemia/reperfusion injury, Parkinson's disease, Alzheimer's disease, neurodegenerative diseases, and other age-related degenerative changes. ROS can be generated at numerous sites within the cell, but the mitochondrial electron transport chain is recognized as the major source of intracellular ROS. Two mitochondrial electron-transfer complexes are major sources of ROS: complex I and complex III. Oxidative damage to either of these complexes, or to electron transport complexes that are in close proximity to these ROS sources, e.g., cytochrome c oxidase, would be expected to inhibit electron transport. Such inhibition would lead to increased electron leakage and more ROS production, much like the well-known effect of adding electron transport inhibitors. Recent studies reveal that ROS and lipid peroxidation products are effective inhibitors of the electron-transport complexes. In some cases, inactivation of enzymes correlates with chemical modification of only a small number of unusually reactive amino acids. In this article, we review current knowledge of ROS-induced alterations within three complexes: (1) complex IV; (2) complex III; and (3) complex I. Our goal is to identify "hot spots" within each complex that are easily chemically modified and could be responsible for ROS-induced inhibition of the individual complexes. Special attention has been placed on ROS-induced damage to cardiolipin that is tightly bound to each of the inner membrane protein complexes. Peroxidation of the bound cardiolipin is thought to be particularly important since its close proximity and long residence time on the protein make it an especially effective reagent for subsequent ROS-induced damage to these proteins.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22856385     DOI: 10.3109/10715762.2012.717273

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  59 in total

Review 1.  Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain.

Authors:  Marco Sisignano; Ralf Baron; Klaus Scholich; Gerd Geisslinger
Journal:  Nat Rev Neurol       Date:  2014-11-04       Impact factor: 42.937

2.  Respiratory chain protein turnover rates in mice are highly heterogeneous but strikingly conserved across tissues, ages, and treatments.

Authors:  Pabalu P Karunadharma; Nathan Basisty; Ying Ann Chiao; Dao-Fu Dai; Rachel Drake; Nick Levy; William J Koh; Mary J Emond; Shane Kruse; David Marcinek; Michael J Maccoss; Peter S Rabinovitch
Journal:  FASEB J       Date:  2015-05-14       Impact factor: 5.191

3.  Mitochondrial Sirt3 Expression is Decreased in APP/PS1 Double Transgenic Mouse Model of Alzheimer's Disease.

Authors:  Wenxiu Yang; Yan Zou; Man Zhang; Nan Zhao; Qi Tian; Min Gu; Wei Liu; Rui Shi; Yang Lü; Weihua Yu
Journal:  Neurochem Res       Date:  2015-06-05       Impact factor: 3.996

Review 4.  Molecular strategies for targeting antioxidants to mitochondria: therapeutic implications.

Authors:  Nadezda Apostolova; Victor M Victor
Journal:  Antioxid Redox Signal       Date:  2015-03-10       Impact factor: 8.401

Review 5.  Nature and Implications of Oxidative and Nitrosative Stresses in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2016-07-13       Impact factor: 3.199

Review 6.  Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry.

Authors:  G Morris; A J Walker; K Walder; M Berk; W Marx; A F Carvalho; M Maes; B K Puri
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

Review 7.  Mitochondrial toxicity of tobacco smoke and air pollution.

Authors:  Jessica L Fetterman; Melissa J Sammy; Scott W Ballinger
Journal:  Toxicology       Date:  2017-08-22       Impact factor: 4.221

8.  SLC25A10 biallelic mutations in intractable epileptic encephalopathy with complex I deficiency.

Authors:  Giuseppe Punzi; Vito Porcelli; Matteo Ruggiu; Md F Hossain; Alessio Menga; Pasquale Scarcia; Alessandra Castegna; Ruggiero Gorgoglione; Ciro L Pierri; Luna Laera; Francesco M Lasorsa; Eleonora Paradies; Isabella Pisano; Carlo M T Marobbio; Eleonora Lamantea; Daniele Ghezzi; Valeria Tiranti; Sergio Giannattasio; Maria A Donati; Renzo Guerrini; Luigi Palmieri; Ferdinando Palmieri; Anna De Grassi
Journal:  Hum Mol Genet       Date:  2018-02-01       Impact factor: 6.150

9.  The mitochondrial cardiolipin remodeling enzyme lysocardiolipin acyltransferase is a novel target in pulmonary fibrosis.

Authors:  Long Shuang Huang; Biji Mathew; Haiquan Li; Yutong Zhao; Shwu-Fan Ma; Imre Noth; Sekhar P Reddy; Anantha Harijith; Peter V Usatyuk; Evgeny V Berdyshev; Naftali Kaminski; Tong Zhou; Wei Zhang; Yanmin Zhang; Jalees Rehman; Sainath R Kotha; Travis O Gurney; Narasimham L Parinandi; Yves A Lussier; Joe G N Garcia; Viswanathan Natarajan
Journal:  Am J Respir Crit Care Med       Date:  2014-06-01       Impact factor: 21.405

10.  Hyperlipidemia and the development of diabetic retinopathy: Comparison between type 1 and type 2 animal models.

Authors:  Renu A Kowluru; Manish Mishra; Anjaneyulu Kowluru; Binit Kumar
Journal:  Metabolism       Date:  2016-07-30       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.